Cardio3 BioSciences to Participate at the KBC Securities Benelux Biotech Healthcare Conference in New York on November 13 & 14
Published: Oct 14, 2013
MONT-SAINT-GUIBERT, Belgium, October 14, 2013 /PRNewswire/ --
The Belgian biotechnology company Cardio3 BioSciences (C3BS), leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, announces its participation for 2013 edition of the KBC Securities Benelux Biotech Healthcare Conference in New York on November 13 & 14, 2013.
Help employers find you! Check out all the jobs and post your resume.